NCATS Assay Guidance Manual Program Workshops
NCATS Assay Guidance Manual Program Workshops
The NCATS AGM program offers training workshops on high-throughput screening and lead discovery, as well as workshops and symposia focused on timely drug discovery and public health challenges. These workshops introduce best practices in early drug discovery and have attracted audiences from academia, government, and pharmaceutical/biotechnology laboratories. The workshops also introduce the scientific community to new technologies and provide participants with opportunities to engage with established drug discovery experts.
The AGM program hosts both our core workshops on high-throughput screening and lead discovery, and also topic-focused workshops. Many of our past workshops are available to stream from the HTS Workshops and Topic-focused Workshops tabs above.
The AGM program is a world-class source of guidelines and best practices for advancing translational science and research in the preclinical development of novel therapeutics and offers training and insight for those desiring to become translational scientists. This program provides scientists with community-developed best laboratory practices in early translational research, including robust assay development, analytical technologies, data analysis tools and preclinical drug discovery standards. The program also aims to help the preclinical drug discovery workforce understand the value of robust, reproducible and replicable results.
The AGM program provides multiple resources, including the AGM eBook. This manual contains best practices in preclinical drug discovery and is free and publicly available from the National Library of Medicine; its editorial board has members from both the private and public sectors.
The program offers in-person and virtual multiday training workshops and conferences.
In addition, the AGM program participates in collaborative research initiatives focused on bottlenecks in translational sciences, such as reproducibility, assay artifacts and interferences, and establishing best practices for preclinical translation.
The AGM program also hosts a webinar series designed to disseminate critical information about preclinical translational science and is particularly relevant for biomedical researchers that are conducting preclinical studies to advance research leading to interventions that will impact human health. This virtual series runs quarterly and hosts prominent speakers in the field. Click here for more information and to register.
Questions? Contact abigail.grossman@nih.gov